Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)

INTRODUCTION: Current evidence indicates that rivaroxaban may be a safe and effective alternative to warfarin among patients with nonvalvular atrial fibrillation (NVAF) and obesity. However, evidence regarding the impact of polypharmacy is limited in this population. The present study evaluated the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Adv Ther
Asıl Yazarlar: Berger, Jeffrey S., Laliberté, François, Kharat, Akshay, Lejeune, Dominique, Moore, Kenneth Todd, Jung, Young, Lefebvre, Patrick, Ashton, Veronica
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8280049/
https://ncbi.nlm.nih.gov/pubmed/34031859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01746-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller